The ECHAS app (Emergency Call for Heart Attack and Stroke) is being developed by experts at UVA Health, Harvard, Northeastern and other leading institutions.
The service delivers a personalised breast cancer prevention plan based on each woman’s genetic profile using a simple home saliva test and online clinical guidance.
The analysis of biological samples from more than 1,000 people also revealed metabolic shifts associated with changing disease severity and with genetic mutations known to increase the risk for colorectal cancer.
The model, called Sybil, which was originally developed using National Lung Screening Trial (NLST) data by investigators from the Massachusetts Institute of Technology and Harvard Medical School, could be used to guide more personalized lung cancer screening strategies.